Birmingham hospital uses Roche automation solution at blood sciences laboratory
News Jun 02, 2012
The University Hospitals Birmingham NHS Foundation Trust has opened a brand new automated blood sciences laboratory at the new Queen Elizabeth Hospital Birmingham.
Equipped with state-of-the-art Roche analytical platforms and track system, the new laboratory ensures a very efficient workflow and will reduce turnaround times (TAT) for routine, high throughput work.
The track system consists of two cobas 8000 platforms (one with two cobas c 701 chemistry modules and two cobas e 602 immunoassay modules and the other with one cobas c 701 and two cobas e 602 modules), a modular pre-analytics module and a cobas p 501/701 post-analytical unit for automated sample storage and retrieval.
“The fully automated track system with pre and post analytics has eliminated the need for manual transfer and storage of samples once they are loaded on the system”, explains Laboratory Manager, Chris Gaskin.
“The cobas 8000 platforms are designed for high throughput and the whole Roche solution has helped us to be more LEAN in our processes and is much more TAT efficient for our high workloads.”
The laboratory also has a standalone cobas p 512 module for automated sample receipt. “In the next few months, we aim to introduce a pneumatic sample delivery system and ward order communications throughout the hospital”, Chris concludes.
“When a test is requested on the ward, a barcode label will be printed automatically. Then, when samples arrive in the laboratory, they will be loaded directly onto the cobas p 512. The system will register receipt on LIMS (Laboratory Information Management System) and then sort the samples into appropriate racks, depending on their destination.
“This will eliminate the need for paperwork, allowing the process to be entirely electronic from request to result for the very first time. It will streamline sample reception significantly and will further reduce turnaround times.”
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018
EMBL Course: Analysis and Integration of Transcriptome and Proteome Data
Mar 12 - Mar 16, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018